Valeritas’ $53 Million Initial Public Offering

Cooley advised the underwriters on Valeritas Holdings’ $52.5 million initial public offering of 5,250,000 shares of common stock. The underwriters have a 30-day option to purchase an additional 787,500 shares.

Cowen and Company and Wedbush PacGrow acted as joint book-running managers for the offering. Roth Capital Partners and B Riley & Co acted as co-managers.

Valeritas, which is headquartered in Bridgewater, New Jersey, and trades on The NASDAQ Capital Market under “VLRX,” is a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies.

Cooley has advised with a team including Div Gupta (Picture), Brent Siler, Brian Leaf, Mark Ballantyne, Jason Saxe, Natasha Leskovsek, Sarah diFrancesca, Bill Christiansen, Jeremy Naylor, Stephanie Gentile and Darren DeStefano.

Involved fees earner: Div Gupta – Cooley LLP; Brent Siler – Cooley LLP; Brian Leaf – Cooley LLP; Mark Ballantyne – Cooley LLP; Jason Saxe – Cooley LLP; Natasha Leskovsek – Cooley LLP; Sarah diFrancesca – Cooley LLP; Bill Christiansen – Cooley LLP; Jeremy Naylor – Cooley LLP; Stephanie Gentile – Cooley LLP; Darren DeStefano – Cooley LLP;

Law Firms: Cooley LLP;

Clients: Roth Capital Partners, LLC; Cowen and Company; B. Riley & Co; Wedbush PacGrow;

Print Friendly, PDF & Email

Author: Ambrogio Visconti